Ardent Health price target lowered to $12 from $13 at RBC Capital
RBC Capital analyst Ben Hendrix lowered the firm's price target on Ardent Health to $12 from $13 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Healthcare Services and Managed Care. The firm is expecting payor strength seen since April to sustain amid growing c